COMPETITIVE IMPACTS AFTER GENERIC MEDICINES ENTRY IN THE BRAZILIAN PHARMACEUTICAL MARKET (2003-2007)

Authors

  • Alexis Toríbio Dantas UNIVERSIDADE DO ESTADO DO RIO DE JANEIRO
  • Pedro Alerrandro Saccol Mendonça UERJ

DOI:

https://doi.org/10.22456/2176-5456.17460

Keywords:

Regulation. Pharmaceutical market. Generic drugs. Relevant market.

Abstract

In 1999, the generic medicines market was created in Brazil. Thus, a new phase of the Brazilian pharmaceutical market began. Through data provided by Anvisa on the Brazilian retail market, aimed to test in how far the generic drug policy has been successful, we used panel data to analyze the impact of the entry of generic drugs on the market structure, as well as the impact on prices and quantities sold between 2003 and 2007. The results were favorable to the policy as they show decrease of the concentration level in the relevant markets of the sample and also increase of the quantity sold. Regarding prices, the model was negligible, probably due to generic drug policy being an instrument of indirect price control.

Downloads

Download data is not yet available.

Author Biographies

Alexis Toríbio Dantas, UNIVERSIDADE DO ESTADO DO RIO DE JANEIRO

Doutor em Economia pelo Insituto de Economia Industrial da UFRJ. Professor Adjunto da Faculdade de Ciências Econômicas da UERJ (Departamento de Evolução Econômica).

Pedro Alerrandro Saccol Mendonça, UERJ

Mestre em Economia pela Faculdade de Ciências Econômicas da UERJ.

Published

2014-09-02

How to Cite

Dantas, A. T., & Mendonça, P. A. S. (2014). COMPETITIVE IMPACTS AFTER GENERIC MEDICINES ENTRY IN THE BRAZILIAN PHARMACEUTICAL MARKET (2003-2007). Análise Econômica, 32(62). https://doi.org/10.22456/2176-5456.17460